PATIENT-CENTRIC | QUALITY-MINDED
Dr. Prasanna Sagar, Director and CEO
Raghunandan Shurpali, Head, Sterile Operations
Raghunandan Shurpali, Head, Sterile Operations
Dr. Sagar has extensive experience in injectable R&D. His expertise spans the formulation design and commercialization of sterile injectable products. A recognized specialist in paragraph-IV filings' legal and technical aspects, he has successfully contributed to multiple high-stakes ANDA submissions for the U.S. market. He is the assignee on several patent applications. He serves on several academic and research councils, syllabus boards, and committees. He holds an M. Pharm and Ph.D. in pharmaceutics.
Raghunandan Shurpali, Head, Sterile Operations
Raghunandan Shurpali, Head, Sterile Operations
Raghunandan Shurpali, Head, Sterile Operations
Mr. Raghu is a pharmacy postgraduate and a Six Sigma Green Belt with extensive experience in quality assurance and parenteral manufacturing, including auto-injectors, PFS, and infusion bags. He has led complex sterile product investigations and implemented visual inspection procedures for challenging products. His expertise includes aseptic process simulation, visual inspection, recording of interventions, regulatory audit management, track-and-trace, sterility investigations, training and other software tools.
Chandu Kankanala, Director and Founder
Chandu Kankanala, Director and Founder
Chandu Kankanala, Director and Founder
Mr. Chandu Kankanala is a pharmacy graduate with a multifaceted industry background. As the Founder of ITAAN PHARMA, he is dedicated to ensuring the availability of quality injectable formulations for patients in need. In addition, Mr. Chandu spearheads the delivery of end-to-end business solutions across banking, healthcare, insurance, retail, engineering, manufacturing, and various agencies. He is recognized for his client-centric and results-driven approach.
Dr. Ajay Babu Pazhayattil, Partner
Chandu Kankanala, Director and Founder
Chandu Kankanala, Director and Founder
Dr. Pazhayattil is a management consultant and industrial pharmacist with a sterile, solid oral and API background. He has leadership roles with top North American brands, generics, and CDMOs. He specializes in technology transfer and process validation and is known for his data-driven and compliant approaches. Dr. Pazhayattil has led many remediation efforts related to U.S. FDA warning letters. He is recognized as a thought leader and is the lead author of AAPS, PDA, ISPE, and RAPS industry guidance and textbooks.